{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:30:44Z","timestamp":1794756644454,"version":"4.9.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030065"],"award-info":[{"award-number":["32030065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92049304"],"award-info":[{"award-number":["92049304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32150030"],"award-info":[{"award-number":["32150030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32121005"],"award-info":[{"award-number":["32121005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20530"],"award-info":[{"award-number":["U23A20530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["2019-I2M-5\\u2013013"],"award-info":[{"award-number":["2019-I2M-5\\u2013013"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1415500"],"award-info":[{"award-number":["22ZR1415500"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011513","name":"State Key Laboratory of Bioreactor Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biomaterials.2025.123694","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:03:01Z","timestamp":1757491381000},"page":"123694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation"],"prefix":"10.1016","volume":"326","author":[{"given":"Xier","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2340-1109","authenticated-orcid":false,"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-6998","authenticated-orcid":false,"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123694_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib2","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1021\/acsnano.3c03217","article-title":"Nanoparticle-mediated RNA therapy attenuates nonalcoholic steatohepatitis and related fibrosis by targeting activated hepatic stellate cells","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123694_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2025.123694_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2025.123694_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.biomaterials.2025.123694_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib9","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"REGENERATE Study Investigators, Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123694_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109953","article-title":"Obeticholic acid orchestrates the crosstalk between ileal autophagy and tight junctions in non-alcoholic steatohepatitis: role of TLR4\/TGF-\u03b21 axis","volume":"361","author":"Tawfiq","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biomaterials.2025.123694_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"NASH Clinical Research Network, Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123694_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/med.21991","article-title":"FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid","volume":"44","author":"Wang","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biomaterials.2025.123694_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2025.123694_bib14","article-title":"Hepatic-accumulated obeticholic acid and atorvastatin self-assembled nanocrystals potentiate ameliorative effects in treatment of metabolic-associated fatty liver disease","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2025.123694_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","article-title":"NASH CRN, Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis","volume":"72","author":"Siddiqui","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.actbio.2024.06.014","article-title":"Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis","volume":"184","author":"Qin","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123694_bib18","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.cmet.2024.08.010","article-title":"Myeloid beta-arrestin 2 depletion attenuates metabolic dysfunction-associated steatohepatitis via the metabolic reprogramming of macrophages","volume":"36","author":"Wei","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.biomaterials.2025.123694_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2025.123694_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib21","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2025.123694_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154914","article-title":"CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1\/M2 status in mice","volume":"125","author":"Xu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.biomaterials.2025.123694_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"O","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2017.06.017","article-title":"ROR\u03b1 induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis","volume":"20","author":"Han","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2025.123694_bib25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib26","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1021\/acsnano.3c03959","article-title":"Capsulated cellular nanosponges for the treatment of experimental inflammatory bowel disease","volume":"17","author":"Duan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123694_bib27","first-page":"480","article-title":"An ischemic area-targeting, peroxynitrite-responsive, biomimetic carbon monoxide nanogenerator for preventing myocardial ischemia-reperfusion injury","volume":"28","author":"Zhang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","article-title":"M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization","volume":"341","author":"Li","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123694_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407115","article-title":"Pyroptotic-spatiotemporally selective delivery of siRNA against pyroptosis and autoimmune diseases","volume":"36","author":"Pan","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib30","doi-asserted-by":"crossref","first-page":"15166","DOI":"10.1021\/acsnano.1c05618","article-title":"Biomimetic nanoparticles carrying a repolarization agent of tumor-associated macrophages for remodeling of the inflammatory microenvironment following photothermal therapy","volume":"15","author":"Yue","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123694_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jconrel.2024.11.033","article-title":"Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke","volume":"378","author":"Zhang","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123694_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122036","article-title":"Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage","volume":"295","author":"Zhou","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123694_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado6798","article-title":"Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis","volume":"10","author":"Luo","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123694_bib34","article-title":"M2 macrophage hybrid membrane-camouflaged targeted biomimetic nanosomes to reprogram inflammatory microenvironment for enhanced enzyme-thermo-immunotherapy","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202370260","article-title":"M2 macrophage membrane-mediated biomimetic-nanoparticle carrying COX-siRNA targeted delivery for prevention of tendon adhesions by inhibiting inflammation","volume":"19","author":"Sun","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123694_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-024-01715-0","article-title":"Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis","author":"Xu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001808","article-title":"Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity","volume":"32","author":"Jiang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib38","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jconrel.2025.02.036","article-title":"Chemotaxis-driven hybrid liposomes recover intestinal homeostasis for targeted colitis therapy","volume":"380","author":"Pan","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123694_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf7820","article-title":"Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs","volume":"7","author":"Park","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123694_bib40","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.biomaterials.2025.123694_bib41","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2025.123694_bib42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2025.123694_bib43","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.apsb.2024.02.017","article-title":"A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment","volume":"14","author":"Fu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123694_bib44","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/db20-0856","article-title":"Defective FXR-SHP regulation in obesity aberrantly increases miR-802 expression, promoting insulin resistance and fatty liver","volume":"70","author":"Seok","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.biomaterials.2025.123694_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.actbio.2023.04.002","article-title":"Oligochitosan-based nanovesicles for nonalcoholic fatty liver disease treatment via the FXR\/miR-34a\/SIRT1 regulatory loop","volume":"164","author":"Kong","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.sajb.2022.05.008","article-title":"Hypotriglyceridemic and hepatoprotective effect of pumpkin (Cucurbita moschata) seed flour in an experimental model of dyslipidemia","volume":"151","author":"de Farias","year":"2022","journal-title":"South Afr. J. Bot."},{"key":"10.1016\/j.biomaterials.2025.123694_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib48","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jhep.2021.02.012","article-title":"Targeting cell-intrinsic metabolism for antifibrotic therapy","volume":"74","author":"Gilgenkrantz","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/iep.12519","article-title":"Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction-associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways","volume":"105","author":"Farrash","year":"2024","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/ph17081073","article-title":"Unlocking cholesterol metabolism in metabolic-associated steatotic liver disease: molecular targets and natural product interventions","volume":"17","author":"Li","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biomaterials.2025.123694_bib51","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123694_bib52","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-020-06100-0","article-title":"Fecal microbiota transplantation for chronic liver diseases: current understanding and future direction","volume":"65","author":"Lechner","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biomaterials.2025.123694_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109915","article-title":"Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis","volume":"124","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123694_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1072133","article-title":"Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease","volume":"9","author":"Hao","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biomaterials.2025.123694_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117156","article-title":"Bacteroides ovatus alleviates high-fat and high-cholesterol -induced nonalcoholic fatty liver disease via gut-liver axis","volume":"178","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123694_bib56","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/liv.14899","article-title":"Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease","volume":"41","author":"Lang","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.biomaterials.2025.123694_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2304159","article-title":"Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biomaterials.2025.123694_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6221340","article-title":"Er-chen decoction alleviates high-fat diet-induced nonalcoholic fatty liver disease in rats through remodeling gut microbiota and regulating the serum metabolism","volume":"2022","author":"Miao","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.biomaterials.2025.123694_bib59","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/acs.jproteome.6b00973","article-title":"Metabolic in vivo labeling highlights differences of metabolically active microbes from the mucosal gastrointestinal microbiome between high-fat and normal chow diet","volume":"16","author":"Oberbach","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biomaterials.2025.123694_bib60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00535-022-01909-0","article-title":"Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity","volume":"57","author":"Lin","year":"2022","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib61","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/pharmaceutics15020612","article-title":"Experimental methods for the biological evaluation of nanoparticle-based drug delivery risks","volume":"15","author":"Pandey","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123694_bib62","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biomaterials.2025.123694_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106621","article-title":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","volume":"187","author":"Yan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biomaterials.2025.123694_bib64","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123694_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.908011","article-title":"The role of gut microbiota-bile acids Axis in the progression of non-alcoholic fatty liver disease","volume":"13","author":"Ni","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biomaterials.2025.123694_bib66","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2025.123694_bib67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","article-title":"Diversification of host bile acids by members of the gut microbiota","volume":"11","author":"Winston","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biomaterials.2025.123694_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113186","article-title":"Anti-inflammatory effects of the Aralia elata and Cirsium japonicum in Raw264.7 cells and in vivo colitis model in mice and dogs","volume":"151","author":"Kim","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123694_bib69","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/molecules28062506","article-title":"Payload release profile and anti-cancer stem cell properties of compositionally different polymeric nanoparticles containing a copper(II) complex","volume":"28","author":"Passeri","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2025.123694_bib70","first-page":"422","article-title":"Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles","volume":"34","author":"Yaman","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib71","first-page":"548","article-title":"Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic\/chemo-\/immunotherapy","volume":"20","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123694_bib72","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.7150\/thno.80494","article-title":"A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases","volume":"13","author":"Tao","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2025.123694_bib73","article-title":"Fatty liver\/adipose tissue dual-targeting nanoparticles with heme oxygenase-1 inducer for amelioration of obesity, obesity-induced type 2 diabetes, and steatohepatitis","volume":"9","author":"Hong","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2025.123694_bib74","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","article-title":"Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation","volume":"11","author":"Barbier-Torres","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123694_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade5041","article-title":"Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis","volume":"9","author":"Tong","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123694_bib76","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.11.039","article-title":"Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH","volume":"341","author":"Maeda","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123694_bib77","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"NASH Clinical Research Network (CRN), Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225006131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225006131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:52:19Z","timestamp":1780303939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225006131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":77,"alternative-id":["S0142961225006131"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123694","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123694"}}